-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on United Therapeutics, Raises Price Target to $660

Benzinga·03/30/2026 13:34:53
Listen to the news
TD Cowen analyst Joseph Thome maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $575 to $660.